These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 36920318)

  • 21. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
    Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H
    Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfection of short-interfering RNA silences adhesion molecule expression on cardiac microvascular cells.
    Walker T; Saup E; Nolte A; Simon P; Kornberger A; Steger V; Adolph O; Wendel HP
    Thorac Cardiovasc Surg; 2011 Sep; 59(6):322-8. PubMed ID: 21692023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The enhancement of gene silencing efficiency with chitosan-coated liposome formulations of siRNAs targeting HIF-1α and VEGF.
    Şalva E; Turan SÖ; Eren F; Akbuğa J
    Int J Pharm; 2015 Jan; 478(1):147-154. PubMed ID: 25445537
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyene-based cationic lipids as visually traceable siRNA transfer reagents.
    Jubeli E; Raju L; Khalique NA; Bk N; Zegel C; Chen A; Lou HH; Øpstad CL; Zeeshan M; Sliwka HR; Partali V; Leopold PL; Pungente MD
    Eur J Pharm Biopharm; 2015 Jan; 89():280-9. PubMed ID: 25536113
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Engineered ionizable lipid siRNA conjugates enhance endosomal escape but induce toxicity in vivo.
    Biscans A; Ly S; McHugh N; Cooper DA; Khvorova A
    J Control Release; 2022 Sep; 349():831-843. PubMed ID: 35917865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Targeted Transfection Using PEGylated Cationic Liposomes Directed Towards P-Selectin Increases siRNA Delivery into Activated Endothelial Cells.
    Constantinescu CA; Fuior EV; Rebleanu D; Deleanu M; Simion V; Voicu G; Escriou V; Manduteanu I; Simionescu M; Calin M
    Pharmaceutics; 2019 Jan; 11(1):. PubMed ID: 30669699
    [No Abstract]   [Full Text] [Related]  

  • 27. Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages.
    Nogueira E; Freitas J; Loureiro A; Nogueira P; Gomes AC; Preto A; Carmo AM; Moreira A; Cavaco-Paulo A
    Colloids Surf B Biointerfaces; 2017 Jul; 155():459-465. PubMed ID: 28472749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of mouse VCAM-1 by vector-based siRNA.
    Alam AK; Florey O; Weber M; Pillai RG; Chan C; Tan PH; Lechler RI; McClure MO; Haskard DO; George AJ
    Transpl Immunol; 2006 Nov; 16(3-4):185-93. PubMed ID: 17138052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cationic Liposomes Carrying siRNA: Impact of Lipid Composition on Physicochemical Properties, Cytotoxicity and Endosomal Escape.
    Lechanteur A; Sanna V; Duchemin A; Evrard B; Mottet D; Piel G
    Nanomaterials (Basel); 2018 Apr; 8(5):. PubMed ID: 29695068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient downregulation of VEGF in retinal pigment epithelial cells by integrin ligand-labeled liposome-mediated siRNA delivery.
    Chen CW; Yeh MK; Shiau CY; Chiang CH; Lu DW
    Int J Nanomedicine; 2013; 8():2613-27. PubMed ID: 23901275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of the combination of cationic lipid and phospholipid on gene-knockdown using siRNA lipoplexes in breast tumor cells and mouse lungs.
    Hattori Y; Tang M; Aoki A; Ezaki M; Sakai H; Ozaki KI
    Mol Med Rep; 2023 Oct; 28(4):. PubMed ID: 37594053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice.
    Soleimani A; Mirzavi F; Nikoofal-Sahlabadi S; Nikpoor AR; Taghizadeh B; Barati M; Soukhtanloo M; Jaafari MR
    Sci Rep; 2022 Jun; 12(1):10423. PubMed ID: 35729230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
    Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
    J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and preliminary investigations of the siRNA delivery potential of novel, single-chain rigid cationic carotenoid lipids.
    Pungente MD; Jubeli E; Øpstad CL; Al-Kawaz M; Barakat N; Ibrahim T; Abdul Khalique N; Raju L; Jones R; Leopold PL; Sliwka HR; Partali V
    Molecules; 2012 Mar; 17(3):3484-500. PubMed ID: 22426529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship Between the Physicochemical Properties of Lipid Nanoparticles and the Quality of siRNA Delivery to Liver Cells.
    Sato Y; Hatakeyama H; Hyodo M; Harashima H
    Mol Ther; 2016 Apr; 24(4):788-95. PubMed ID: 26678452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes.
    Bender HR; Kane S; Zabel MD
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery.
    Tagalakis AD; He L; Saraiva L; Gustafsson KT; Hart SL
    Biomaterials; 2011 Sep; 32(26):6302-15. PubMed ID: 21624650
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The development of tertiary amine cationic lipids for safe and efficient siRNA delivery.
    Lin Z; Bao M; Yu Z; Xue L; Ju C; Zhang C
    Biomater Sci; 2019 Jul; 7(7):2777-2792. PubMed ID: 31041934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and characterization of siRNA lipoplexes: Effect of different lipids, in vitro evaluation in cancerous cell lines and in vivo toxicity study.
    Khatri N; Baradia D; Vhora I; Rathi M; Misra A
    AAPS PharmSciTech; 2014 Dec; 15(6):1630-43. PubMed ID: 25145330
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of long-circulating cationic nanoparticle formulations consisting of a two-stage PEGylation step for the delivery of siRNA in a breast cancer tumor model.
    Ho EA; Osooly M; Strutt D; Masin D; Yang Y; Yan H; Bally M
    J Pharm Sci; 2013 Jan; 102(1):227-36. PubMed ID: 23132529
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.